EUCR
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
EUCR
Delisted
EUCR was delisted on the 26th of April, 2023.
39 hedge funds and large institutions have $73.2M invested in Eucrates Biomedical Acquisition Corp. Ordinary Shares in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
–
Holders Change %
0%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
13
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$5.1M |
| 2 |
SCM
Saba Capital Management
New York
|
+$2.11M |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$780K |
| 4 |
WRBC
W.R. Berkley Corp
Greenwich,
Connecticut
|
+$779K |
| 5 |
SC
Sculptor Capital
New York
|
+$753K |
